Crossmark

Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate

Crossref DOI link: https://doi.org/10.1038/nbt.3697

Published Online: 2016-10-10

Published Print: 2016-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stevens, Mark M

Maire, Cecile L

Chou, Nigel

Murakami, Mark A

Knoff, David S

Kikuchi, Yuki

Kimmerling, Robert J

Liu, Huiyun

Haidar, Samer

Calistri, Nicholas L

Cermak, Nathan

Olcum, Selim https://orcid.org/0000-0002-6417-1007
Cordero, Nicolas A

Idbaih, Ahmed

Wen, Patrick Y

Weinstock, David M

Ligon, Keith L

Manalis, Scott R
License Information

Text and Data Mining valid from 2016-10-10
More Information

Article History

Received: 23 November 2015

Accepted: 30 August 2016

First Online: 10 October 2016

Competing interests

: S.R.M. is a cofounder of Affinity Biosensors, which develops techniques relevant to the research presented. S.O. and M.M.S. anticipate employment at Affinity Biosensors. D.M.W. is a consultant for and receives research support from Novartis.